Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0068 | 0.7404 | 0.6243 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0076 | 0.8512 | 0.8512 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.3091 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.3091 | 0.5 |
Onchocerca volvulus | 0.0068 | 0.7404 | 0.5 | |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0087 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.3091 | 0.3091 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.9669 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.3091 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.3091 | 0.3996 |
Echinococcus multilocularis | jun protein | 0.0087 | 1 | 1 |
Echinococcus granulosus | jun protein | 0.0087 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.7736 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.3091 | 0.3091 |
Schistosoma mansoni | jun-related protein | 0.007 | 0.7736 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.3091 | 0.3996 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.3091 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0087 | 1 | 1 |
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.0076 | 0.8512 | 0.8512 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 35.82 umol/L | Cytotoxicity against human Bel7402 cells after 48 hrs by MTT based ELISA | ChEMBL. | 21504204 |
IC50 (functional) | = 37.14 umol/L | Cytotoxicity against human SMMC7721 cells after 48 hrs by MTT based ELISA | ChEMBL. | 21504204 |
IC50 (functional) | > 50 umol/L | Cytotoxicity against human HepG2 cells after 48 hrs by MTT based ELISA | ChEMBL. | 21504204 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.